Fred Alger Management Inc. purchased a new position in shares of Teladoc Inc (NYSE:TDOC) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 16,500 shares of the health services provider’s stock, valued at approximately $575,000.
A number of other large investors have also recently bought and sold shares of TDOC. SG Americas Securities LLC acquired a new position in Teladoc in the 4th quarter valued at about $101,000. Montag A & Associates Inc. acquired a new position in Teladoc in the 4th quarter valued at about $200,000. Buckley Wealth Management LLC acquired a new position in Teladoc in the 4th quarter valued at about $221,000. California Public Employees Retirement System acquired a new position in Teladoc in the 2nd quarter valued at about $260,000. Finally, Oppenheimer & Co. Inc. acquired a new position in Teladoc in the 3rd quarter valued at about $262,000.
A number of equities research analysts have recently issued reports on the stock. KeyCorp reissued a “buy” rating and issued a $41.00 price target on shares of Teladoc in a research note on Wednesday, January 10th. Jefferies Group assumed coverage on shares of Teladoc in a research note on Friday, January 26th. They issued a “buy” rating and a $40.00 price target on the stock. ValuEngine raised shares of Teladoc from a “sell” rating to a “hold” rating in a research note on Sunday, December 31st. Deutsche Bank downgraded shares of Teladoc from a “buy” rating to a “hold” rating and set a $45.00 target price on the stock. in a research note on Thursday, March 15th. Finally, Citigroup started coverage on shares of Teladoc in a research note on Thursday, January 4th. They set a “buy” rating on the stock. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $41.67.
Shares of Teladoc stock opened at $39.15 on Friday. Teladoc Inc has a 12-month low of $22.73 and a 12-month high of $44.65. The company has a quick ratio of 3.87, a current ratio of 3.87 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $2,515.35, a PE ratio of -23.73 and a beta of 0.36.
Teladoc (NYSE:TDOC) last issued its earnings results on Tuesday, February 27th. The health services provider reported ($0.50) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.40) by ($0.10). Teladoc had a negative net margin of 45.77% and a negative return on equity of 20.95%. The company had revenue of $77.14 million during the quarter, compared to analyst estimates of $76.14 million. research analysts expect that Teladoc Inc will post -1.37 earnings per share for the current year.
In other Teladoc news, insider Adam C. Vandervoort sold 47,123 shares of the company’s stock in a transaction on Monday, March 5th. The shares were sold at an average price of $39.36, for a total transaction of $1,854,761.28. Following the completion of the transaction, the insider now owns 19,338 shares in the company, valued at approximately $761,143.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Andrew Turitz sold 36,210 shares of the company’s stock in a transaction on Tuesday, March 6th. The stock was sold at an average price of $40.39, for a total transaction of $1,462,521.90. Following the transaction, the senior vice president now owns 16,700 shares of the company’s stock, valued at approximately $674,513. The disclosure for this sale can be found here. In the last quarter, insiders have sold 364,494 shares of company stock valued at $14,665,947. 4.47% of the stock is owned by company insiders.
ILLEGAL ACTIVITY NOTICE: This piece was posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2018/04/07/16500-shares-in-teladoc-inc-tdoc-purchased-by-fred-alger-management-inc.html.
Teladoc Company Profile
Teladoc, Inc is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company’s solution connects its Members, with its over 3,000 board certified physicians and behavioral health professionals treating a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.